Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Roche Signs Generic Xofluza Licensing Deal with Medicines Patent Pool for 129 Countries

20/05/2026 Published by vivi

Framework of the Voluntary Licensing Agreement Swiss pharmaceutical corporation Roche has executed a voluntary licensing agreement with the Medicines Patent... Read more

Tags: #Global Trends

AstraZeneca and Roche Diagnostics Partner to Advance Digital Pathology in Asia Pacific

19/05/2026 Published by vivi

Strategic Framework and Jurisdictions AstraZeneca and Roche Diagnostics Asia Pacific have finalized a landmark three-year Memorandum of Understanding (MOU) to... Read more

Category: Uncategorized

Tags: #Global Trends

Eli Lilly Posts Blockbuster Q1 2026 Revenue While Executing Aggressive Diversification M&A Strategy

19/05/2026 Published by vivi

Financial Performance and Incretin Portfolio Dominance Eli Lilly has reported its financial results for the first quarter of 2026, with... Read more

Category: Uncategorized

Tags: #Global Trends

Dark Horse and KunTuo Partner to Streamline Cell and Gene Therapy Trials in China

19/05/2026 Published by vivi

Overview and Objectives of the Alliance California-based Dark Horse Consulting Group and Beijing-based clinical research organization (CRO) KunTuo Research and... Read more

Category: Uncategorized

Tags: #Global Trends

ProtaGene Partners With MilliporeSigma to Deliver End-to-End Biopharmaceutical Testing

19/05/2026 Published by vivi

Overview of the Strategic Alliance ProtaGene has entered into a strategic partnership with the Life Science business of Merck, which... Read more

Category: Uncategorized

Tags: #Global Trends

FDA Grants Dual Approvals for AstraZeneca and Daiichi Sankyo’s Enhertu in Early Breast Cancer

19/05/2026 Published by vivi

Regulatory Milestone and Clinical Indications The US Food and Drug Administration (FDA) has granted regulatory clearance for two new indications... Read more

Category: Uncategorized

Bristol Myers Squibb Evaluates Houston for Potential $1B Manufacturing Expansion

19/05/2026 Published by vivi

Project Specifications and Capital Investment According to a regulatory application filed with state authorities, Bristol Myers Squibb (BMS) is weighing... Read more

Category: Uncategorized

Tags: #Global Trends

Novartis Terminates Plant Lease with Porton, Threatening $64M in Structural Damages

19/05/2026 Published by vivi

Origin and Core of the Contract Dispute Swiss pharmaceutical giant Novartis has unilaterally terminated a plant leasing contract with the... Read more

Category: Uncategorized

Tags: #Global Trends